Oral Cyclic Peptide ADMET Prediction represents the convergence of artificial intelligence and experimental pharmacology, creating a paradigm shift in how absorption, distribution, metabolism, excretion, and toxicity properties are evaluated for cyclic peptide therapeutics. By leveraging machine learning algorithms, physics-based simulations, and validated wet-lab data, our AI-powered ADMET platform transforms traditionally empirical, late-stage profiling into streamlined, predictive intelligence that enables early de-risking and accelerated development while maintaining the highest standards of experimental confirmation.
Figure 1. Oral Cyclic Peptide ADMET Prediction.
We have built the world's only fully integrated ADMET prediction platform specifically optimized for oral cyclic peptides. For the first time, your ADMET assessment—from early screening to regulatory submission—is unified within one comprehensive digital ecosystem that seamlessly combines AI prediction with wet-lab validation. This long-awaited solution simplifies complex pharmacokinetic profiling and eliminates the traditional disconnect between computational predictions and experimental reality. Our approach is unique. We combine a team of highly qualified ADMET scientists with powerful AI-powered prediction software and an integrated wet-lab validation platform. This AI+wet laboratory solution ensures that our technology provides fast and high-precision predictions on all ADMET parameters, while our experimental scientists validate and improve these predictions through rigorous laboratory testing, creating a continuously improving and unparalleled reliability closed-loop system.
Figure 2. Streamlined: oral cyclic peptide ADMET prediction service.
Our AI-integrated ADMET prediction service seamlessly supports a wide range of oral cyclic peptide development activities:
Early-Stage Candidate Screening: Rapidly triage large virtual libraries or early lead series based on predicted ADMET profiles, focusing synthesis and experimental efforts on compounds with the highest probability of success.
Lead Optimization Guidance: Use real-time ADMET predictions to guide medicinal chemistry decisions, identifying modifications that improve permeability, stability, and safety while avoiding unintended liabilities.
Development Risk Assessment: Proactively identify potential ADMET-related development risks early, enabling mitigation strategies before significant resources are committed.
Compound Prioritization: Objectively rank candidates based on integrated ADMET scores, ensuring that the most developable compounds advance to later-stage studies.
We offer a comprehensive suite of AI-driven ADMET prediction services, each supported by integrated wet-lab validation to ensure accuracy and reliability:
Oral Absorption & Permeability Prediction
Our AI models predict intestinal permeability, efflux susceptibility (P-gp), and overall oral absorption potential with industry-leading accuracy. Predictions are validated against Caco-2 and MDCK cell monolayer assays performed in our integrated wet-lab, ensuring that in silico findings are confirmed by experimental data before critical decisions are made.
Metabolic Stability & Clearance Prediction
Advanced machine learning algorithms identify potential metabolic soft spots and predict intrinsic clearance in human and preclinical species. Each prediction is supported by liver microsome and hepatocyte stability studies, with metabolite identification using high-resolution mass spectrometry to confirm predicted metabolic pathways.
Plasma Protein Binding & Distribution Prediction
Our AI platform accurately predicts plasma protein binding rates, volume of distribution, and tissue partitioning for cyclic peptides. Wet-lab validation using equilibrium dialysis methods confirms these predictions, providing the high-quality data required for accurate pharmacokinetic modeling.
Toxicity & Safety Liability Prediction
Comprehensive toxicity prediction covering phospholipidosis, hepatotoxicity, cardiotoxicity (hERG), genotoxicity, and off-target interaction risks. High-risk predictions are flagged for immediate wet-lab follow-up using validated safety assays, ensuring that safety concerns are identified and addressed early.
Our integrated AI-wet-lab ADMET process is designed for accuracy, efficiency, and continuous improvement:
Candidate cyclic peptides are analyzed using our proprietary AI ADMET prediction engine, generating comprehensive profiles across absorption, distribution, metabolism, excretion, and toxicity parameters. Initial predictions provide rapid go/no-go guidance and highlight potential development risks.
Validated compounds undergo systematic wet-lab testing using our in-house ADMET platform, including permeability assays, metabolic stability studies, protein binding measurements, and safety assessments. Results are captured directly in our integrated data management system.
Experimental results are compared against AI predictions to assess model accuracy. Discrepancies are analyzed to identify underlying molecular features that may have been mispredicted, generating insights that refine model performance.
Final ADMET reports present both predicted and validated data in a clear, actionable format. Integrated analysis highlights key risks, opportunities, and recommended next steps, empowering confident development decisions.
Integrated AI-Wet-Lab Platform
Unlike pure computational providers or traditional CROs, we offer a fully integrated platform where AI predictions and wet-lab validation work in concert. This eliminates the disconnect between prediction and experiment, providing confidence that computational insights are grounded in real-world data.
Cyclic Peptide-Specific Models
Our AI models are trained on extensive datasets specifically focused on cyclic peptides, capturing the unique conformational, physicochemical, and ADMET behaviors of this compound class. Generic ADMET tools simply cannot match this specialized accuracy.
Closed-Loop Continuous Improvement
Every wet-lab result feeds back into our AI models, creating a virtuous cycle of continuous improvement. The more we work together, the more accurate our predictions become for your specific chemical space.
Connect with Us Anytime!
The future of oral cyclic peptide ADMET assessment is integrated, intelligent, and evidence-based. By combining the predictive power of AI with the certainty of wet-lab validation, we have created a service that not only accelerates timelines but also provides the confidence needed to advance candidates with conviction. Experience the difference of a truly integrated, closed-loop approach to ADMET profiling. Discover how we can predict, validate, and optimize your cyclic peptide candidates with speed, accuracy, and reliability.
